The Role of Aldosterone and Mineralocorticoid Receptors in Cardiovascular Disease

Author： Funder John W.  

Publisher： Adis International

ISSN： 1175-3277

Source： American Journal of Cardiovascular Drugs, Vol.7, Iss.3, 2007-01, pp. : 151-157

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting the mineralocorticoid receptor in cardiovascular disease

By Young Morag J  

Expert Opinion on Therapeutic Targets, Vol. 17, Iss. 3, 2013-03 ,pp. : 321-331

Informa Healthcare

Access to resources Recommend Favorite

Receptors in cardiovascular disease: review and introduction

By Leonardi A.   Sironi G.   Motta G.  

Pharmaceutica Acta Helvetiae, Vol. 74, Iss. 2, 2000-03 ,pp. : 157-161

Elsevier

Access to resources Recommend Favorite

The Role of Tnf in Cardiovascular Disease

By Ferrari R.  

Pharmacological Research, Vol. 40, Iss. 2, 1999-08 ,pp. : 97-105

Academic Press

Access to resources Recommend Favorite

The Role of AGEs in Cardiovascular Disease

By  

Current Pharmaceutical Design, Vol. 14, Iss. 10, 2008-04 ,pp. : 979-986

Bentham Science Publishers

Access to resources Recommend Favorite

Early Life Stress in Depressive Patients: Role of Glucocorticoid and Mineralocorticoid Receptors and of Hypothalamic-Pituitary-Adrenal Axis Activity

By  

Current Pharmaceutical Design, Vol. 21, Iss. 11, 2015-02 ,pp. : 1369-1378

Bentham Science Publishers

Access to resources Recommend Favorite